Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy "The COMBO - DN (Combination vs Monotherapy of pregaBalin and dulOxetine in Diabetic Neuropathy) Study"

Trial Profile

Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy "The COMBO - DN (Combination vs Monotherapy of pregaBalin and dulOxetine in Diabetic Neuropathy) Study"

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2013

At a glance

  • Drugs Duloxetine (Primary) ; Pregabalin (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms COMBO-DN; HMGQ
  • Most Recent Events

    • 05 Oct 2012 Results from duloxetine monotherapy versus pregabalin monotherapy analysis presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
    • 31 Aug 2012 Results presented at the 14th World Congress on Pain.
    • 15 Mar 2012 This trial is recruting in England, Sweden, Spain, France as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top